Wholly owned by Nestlé and known by the name Nestlé Skin Health since 2014, Galderma was recently divested by the global food giant in a deal valued at 10.2 billion Swiss francs.

New ownership immediately set out to refocus the company as a pure-play dermatology business, restoring the Galderma brand and appointing new leadership, namely CFO Thomas Dittrich and CEO Flemming Ørnskov.

Ørnskov stands among the highest-profile execs in biopharma today. He initially built a reputation for himself as an executive at Bausch & Lomb and Bayer, among others but he is best known for his work as CEO of Shire, where he was credited with growing revenue more than three times over before leading the biotechnology company to a 62-billion-dollar buy out by Japanese multinational pharma company, Takeda.

Dr. Grant Stevens, recently sat down with Dr. Ørnskov for a candid and exclusive interview, in which the new CEO provided a glimpse into his vision and plans for the future of the world's largest independent global dermatology company.

» Apple Podcasts | https://podcasts.apple.com/us/podcast/technology-of-beauty/id1510898426
» Spotify | https://open.spotify.com/show/0hEIiwccpZUUHuMhlyCOAm
» Recent episodes | https://www.influxmarketing.com/technology-of-beauty/
» Instagram | https://www.instagram.com/thetechnologyofbeauty/
» LinkedIn | https://www.linkedin.com/company/the-technology-of-beauty/

The Technology of Beauty is produced by Influx Marketing, The Digital Agency for Aesthetic Practices. https://www.influxmarketing.com/

Want more aesthetic insights? Subscribe to Next Level Practices, the show where we discuss the ever-changing world of digital marketing and patient acquisition and bring you the latest ideas, strategies, and tactics to help you take your practice to the next level. https://www.influxmarketing.com/next-level-practices/